Literature DB >> 23935012

Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.

Daniel J Quinlan1, John W Eikelboom, Jeffrey I Weitz.   

Abstract

Entities:  

Keywords:  Editorials; hemorrhage; prothrombin complex concentrates; randomized controlled trial; warfarin

Mesh：

Substances：

Year:  2013        PMID： 23935012     DOI： 10.1161/CIRCULATIONAHA.113.005107

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  14 in total

1.  Clinical effectiveness and safety outcomes associated with prothrombin complex concentrates.

Authors:  Ashley Hedges; James C Coons; Melissa Saul; Roy E Smith
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

Review 2.  Approaches to prevent bleeding associated with anticoagulants: current status and recent developments.

Authors:  Manu Thomas Kalathottukaren; Charles A Haynes; Jayachandran N Kizhakkedathu
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

3.  An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanisms.

Authors:  Annette von Drygalski; Vikas Bhat; Andrew J Gale; Patricia M Averell; Thomas J Cramer; Darlene J Elias; John H Griffin; Laurent O Mosnier
Journal:  Blood Adv       Date:  2020-08-11

Review 4.  Algorithm for anticoagulation management in geriatric hip fracture patients--Surgeons save Blood.

Authors:  M A Wendl-Soeldner; C W I Moll; C Kammerlander; M Gosch; T Roth
Journal:  Z Gerontol Geriatr       Date:  2014-02       Impact factor: 1.281

5.  The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Jacques Duranteau; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Marc Maegele; Giuseppe Nardi; Louis Riddez; Charles-Marc Samama; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2019-03-27       Impact factor: 9.097

Review 6.  Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients.

Authors:  Mauro Molteni; Mario Bo; Giovanni Di Minno; Giuseppe Di Pasquale; Simonetta Genovesi; Danilo Toni; Paolo Verdecchia
Journal:  Intern Emerg Med       Date:  2017-04-24       Impact factor: 3.397

7.  Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2.

Authors:  Ravi Sarode; Katsuyuki Fukutake; Masahiro Yasaka; Michael A Tortorici; Antoinette Mangione; Marc Pfister; Adam Cuker
Journal:  Blood Adv       Date:  2020-09-08

8.  The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition.

Authors:  Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund A M Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Donat R Spahn
Journal:  Crit Care       Date:  2016-04-12       Impact factor: 9.097

Review 9.  Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism.

Authors:  Daniel M Witt; Nathan P Clark; Scott Kaatz; Terri Schnurr; Jack E Ansell
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

Review 10.  Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation.

Authors:  Oliver Grottke; James Aisenberg; Richard Bernstein; Patrick Goldstein; Menno V Huisman; Dara G Jamieson; Jerrold H Levy; Charles V Pollack; Alex C Spyropoulos; Thorsten Steiner; Gregory J Del Zoppo; John Eikelboom
Journal:  Crit Care       Date:  2016-04-28       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.